Mr. Christopher E Allen, APRN BC Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Not Enrolled in Medicare Practice Location: 71 East Avenue, Ste F, Norwalk, CT 06851 Phone: 203-838-1678 Fax: 203-854-6775 |
Mary Heery, APRN Clinical Nurse Specialist - Oncology Medicare: Medicare Enrolled Practice Location: 34 Maple St, Norwalk, CT 06850 Phone: 203-852-2757 Fax: 203-855-3876 |
Theresa A Cutillo-schmitter, APRN Clinical Nurse Specialist - Psych/Mental Health, Child & Adolescent Medicare: Not Enrolled in Medicare Practice Location: 71 East Ave, Suite V, Norwalk, CT 06851 Phone: 203-656-1452 Fax: 203-656-1485 |
Mrs. Melinda Ethel Brockwell, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 24 Stevens St, Norwalk, CT 06850 Phone: 203-852-2148 Fax: 203-852-3109 |
Ellen Rogan, A.P.R.N. Clinical Nurse Specialist - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 24 Stevens St, Norwalk, CT 06850 Phone: 203-952-3093 |
Mrs. Bridget Eileen Debartolomeo, RN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 24 Stevens St, Norwalk, CT 06856 Phone: 203-852-2000 |
Jacquelyn A Meyer, APRN Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Medicare Enrolled Practice Location: 71 East Ave, Suite V, Norwalk, CT 06851 Phone: 203-656-1452 Fax: 203-656-1485 |
Mrs. Therese Francesca Gardere, CPNP Clinical Nurse Specialist - Pediatrics Medicare: Medicare Enrolled Practice Location: 747 Belden Ave, Norwalk, CT 06850 Phone: 914-493-8628 |
News Archive
St. Joseph's Hospital and Medical Center in Phoenix announced on Tuesday that it will continue to provide life-saving abortion care to patients even though it means losing its affiliation with the local Roman Catholic Diocese (12/23).
Dayan B. Goodenowe and colleagues report in the November 2007 issue of the Journal of Lipid Research that people with Alzheimer's disease and related conditions exhibit decreased blood levels of an important brain chemical called ethanolamine plasmalogen, even at the very early stages of the disease.
Researchers at the University of Cincinnati have found in a retrospective study that African-American men are less likely to use a more targeted biopsy option for prostate cancer, despite an increased incidence in this group of patients.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced the publication of new data in the journal Nature Biotechnology by Alnylam scientists and collaborators from Tekmira Pharmaceuticals Corporation, AlCana Technologies, Inc., and The University of British Columbia (UBC). The new study employed a rational design approach for the discovery of novel lipids that can be incorporated into lipid nanoparticles (LNPs) for systemic delivery of RNAi therapeutics.
› Verified 9 days ago